EP Patent

EP3884935A1 — Compounds and methods for inhibiting phosphate transport

Assigned to Ardelyx Inc · Expires 2021-09-29 · 5y expired

What this patent protects

Provided are non-NHE3-binding agents having activity as phosphate transport/uptake inhibitors in the gastrointestinal tract, including in the small intestine, methods for their use as therapeutic or prophylactic agents, and related methods of drug discovery.

USPTO Abstract

Provided are non-NHE3-binding agents having activity as phosphate transport/uptake inhibitors in the gastrointestinal tract, including in the small intestine, methods for their use as therapeutic or prophylactic agents, and related methods of drug discovery.

Drugs covered by this patent

Patent Metadata

Patent number
EP3884935A1
Jurisdiction
EP
Classification
—
Expires
2021-09-29
Drug substance claim
No
Drug product claim
No
Assignee
Ardelyx Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.